|
1
|
Staessen JA, Wang J, Bianchi G and
Birkenhäger WH: Essential hypertension. Lancet. 361:1629–1641.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanner F, von Maltzahn J, Maxeiner S, Toma
I, Sipos A, Krüger O, Willecke K and Peti-Peterdi J: Connexin45 is
expressed in the juxtaglomerular apparatus and is involved in the
regulation of renin secretion and blood pressure. Am J Physiol
Regul Integr Comp Physiol. 295:R371–R380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krattinger N, Capponi A, Mazzolai L,
Aubert JF, Caille D, Nicod P, Waeber G, Meda P and Haefliger JA:
Connexin40 renin regulates production and blood pressure. Kidney
Int. 72:814–822. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schweda F, Kurtz L, de Wit C,
Janssen-Bienhold U, Kurtz A and Wagner C: Substitution of
connexin40 with connexin45 prevents hyperreninemia and attenuates
hypertension. Kidney Int. 75:482–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Figueroa XF, Isakson BE and Duling BR:
Vascular gap junctions in hypertension. Hypertension. 48:804–811.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Wit C: Connexins pave the way for
vascular communication. News Physiol Sci. 19:148–153.
2004.PubMed/NCBI
|
|
7
|
de Wit C, Hoepfl B and Wölfle SE:
Endothelial mediators and communication through vascular gap
junctions. Biol Chem. 387:3–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurtz A: Connexins, renin cell
displacement and hypertension. Curr Opin Pharmacol. 21:1–6. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Figueroa XF and Duling BR: Gap junctions
in the control of vascular function. Antioxid Redox Signal.
11:251–266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brisset AC, Isakson BE and Kwak BR:
Connexin in vascular physiology and pathology. Antioxid Redox
Signal. 11:267–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rummery NM and Hill CE: Vascular gap
junctions and implications for hypertension. Clin Exp Pharmacol
Physiol. 31:659–667. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Severs NJ, Rothery S, Dupont E, Coppen SR,
Yeh HI, Ko YS, Matsushita T, Kaba R and Halliday D:
Immunocytochemical analysis of connexin expression in the healthy
and diseased cardiovascular system. Microsc Res Tech. 52:301–322.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chadjichristos CE, Matter CM, Roth I,
Sutter E, Pelli G, Lüscher TF, Chanson M and Kwak BR: Reduced
connexin43 expression limits neointima formation after balloon
distension injury in hypercholesterolemic mice. Circulation.
113:2835–2843. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watts SW and Webb RC: Vascular gap
junctional communication is increased in mineralocoriocoid-salt
hypertension. Hypertension. 28:888–893. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haefliger JA, Castillo E, Waeber G,
Bergonzelli GE, Aubert JF, Sutter E, Nicod P, Waeber B and Meda P:
Hypertension increases connexin-43 in a tissue-specific manner.
Circulation. 95:1007–1014. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haefliger JA, Demotz S, Braissant O, Suter
E, Waeber B, Nicod P and Meda P: Connexins 40 and 43 are
differentially regulated within the kidneys of rats with
renovascular hypertension. Kidney Int. 60:190–201. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dlugosova K, Okruhlicova L, Mitasikova M,
Sotnikova R, Bernatova I, Weismann P, Slezak J and Tribulova N:
Modulation of connexin-43 by omega-3 fatty acids in the aorta of
old spontaneously hypertension rats. J Physiol Pharmacol. 60:63–69.
2009.PubMed/NCBI
|
|
18
|
Seki A, Nishii K and Hagiwara N: Gap
junctional regulation of pressure, fluid force, and electrical
fields in the epigenetics of cardiac morphogenesis and remodeling.
Life Sci. 129:27–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lagaud G, Karicheti V, Knot HJ, Christ GJ
and Laher I: Inhibitors of gap junctions attenuate myogenic tone in
cerebral arteries. Am J Physiol Heart Circ Physiol.
283:H2177–H2186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matchkov VV, Rahman A, Peng H, Nilsson H
and Aalkjaer C: Junctional and nonjunctional effects of heptanol
and glycyrrhetinic acid derivates in rat mesenteric small arteries.
Br J Pharmacol. 142:961–972. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao HJ, Chen BP, Ren GY, Jin JS, Fan FY,
Gao Q, Bruce I and Xia Q: The Effects of Heptanol on electrical
coupling during ischemia in the perfused isolated rat heart. Conf
Proc IEEE Eng Med Bio Soc. 1:122–125. 2005.
|
|
22
|
Saltman AE, Aksehirli TO, Valiunas V,
Gaudette GR, Matsuyama N, Brink P and Krukenkamp IB: Gap junction
uncoupling protects the heart against ischemia. J Thorac Cardiovasc
Surg. 124:371–376. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun B, Qi X and Jiang J: Heptanol
decreases the incidence of ischemia-induced ventricular arrhythmias
through altering electrophysiological properties and connexin43 in
rat hearts. Biomed Rep. 2:349–353. 2014.PubMed/NCBI
|
|
24
|
Harks EG, de Roos AD, Peters PH, de Haan
LH, Brouwer A, Ypey DL, van Zoelen EJ and Theuvenet AP: Fenamates:
A novel class of reversible gap junction blockers. J Pharmacol Exp
Ther. 298:1033–1041. 2001.PubMed/NCBI
|
|
25
|
Li L, Ma KT, Zhao L and Si JQ: Niflumic
acid hyperpolarizes the smooth muscle cells by opening BK(Ca)
channels through ryanodine-sensitive Ca(2+) release in spiral
modular artery. Sheng Li Xue Bao. 60:743–750. 2008.PubMed/NCBI
|
|
26
|
Ma KT, Li XZ, Li L, Jiang XW, Chen XY, Liu
WD, Zhao L, Zhang ZS and Si JQ: Role of gap junctions in the
contractile response to agonists in the mesenteric artery of
spontaneously hypertensive rats. Hypertens Res. 37:110–115. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li L, Wang R, Ma KT, Li XZ, Zhang CL, Liu
WD, Zhao L and Si JQ: Differential effect of calcium-activated
potassium and chloride channels on rat basilar artery vasomotion. J
Huazhong Univ Sci Technolog Med Sci. 34:482–490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
le Noble FA, Stassen FR, Hacking WJ and
Boudier HA Struijker: Angiogenesis and hypertension. J Hypertens.
16:1563–1572. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Segal SS: Integration of blood flow
control to skeletal muscle: Key role of feed arteries. Acta Physiol
Scand. 168:511–518. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Evans WH and Martin PE: Gap junctions:
Structure and function (review). Mol Membr Biol. 19:121–136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saez JC, Berthoud VM, Branes MC, Martinez
AD and Beyer EC: Plasma membrane channels formed by connexins:
Their regulation and functions. Physiol Rev. 83:1359–1400. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Figueroa XF, Isakson BE and Duling BR:
Connexins: Gaps in our knowledge of vascular function. Physiology
(Bethesda). 19:277–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song D, Liu X, Liu R, Yang L, Zuo J and
Liu W: Connexin 43 hemichannel regulates H9c2 cell proliferation by
modulating intracellular ATP and [Ca2+]. Acta Biochim
Biophys Sin (Shanghai). 42:472–482. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Azzam EI, de Toledo SM and Little JB:
Direct evidence for the participation of gap junction-mediated
intercellular communication in the transmission of damage singals
from alpha-particle irradiated to nonirradiated cells. Proc Natl
Acad Sci USA. 98:473–478. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Wit C, Roos F, Bolz SS, Kirchhoff S,
Krüger O, Willecke K and Pohl U: Impaired conduction of
vasodilation along arterioles in connexin40-deficient mice. Circ
Res. 86:649–655. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Wit C, Roos F, Bolz SS and Pohl U: Lack
of vascular connexin 40 is associated with hypertension and
irregular arteriolar vasomotion. Physiol Genomics. 13:169–177.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lampe PD and Lau AF: Regulation of gap
junctions by phosphorylation of connexins. Arch Biochem Biophys.
384:205–215. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moreno AP and Lau AF: Gap junction channel
gating modulated through protein phosphorylation. Prog Biophys Mol
Biol. 94:107–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Haefliger JA and Meda P: Chronic
hypertension alters the expression of Cx43 in cardiovascular muscle
cells. Braz J Med Biol Res. 33:431–438. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Haefliger JA, Castillo E, Waeber G, Aubert
JF, Nicod P, Waeber B and Meda P: Hypertension differentially
affects the expression of the gap junction protein connexin43 in
cardiac myocytes and aortic smooth muscle cells. Adv Exp Med Biol.
432:71–82. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li L, Zhang W, Shi WY, Ma KT, Zhao L, Wang
Y, Zhang L, Li XZ, Zhu H, Zhang ZS, et al: The enhancement of Cx45
expression and function in renal interlobar artery of spontaneously
hypertensive rats at different age. Kidney Blood Press Res.
40:52–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li XZ, Ma KT, Guan BC, Li L, Zhao L, Zhang
ZS, Si JQ and Jiang ZG: Fenamates block gap junction coupling and
potentiate BKCa channels in guinea pig arteriolar cells. Eur J
Pharmacol. 703:74–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Boittin FX, Alonso F, Le Gal L, Allagnat
F, Bény JL and Haefliger JA: Connexins and M3 muscarinic receptors
contribute to heterogeneous Ca(2+) signaling in mouse aortic
endothelium. Cell Physiol Biochem. 31:166–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rocha ML, Kihara AH, Davel AP, Britto LR,
Rossoni LV and Bendhack LM: Blood pressure variability increases
connexin expression in the vascular smooth muscle of rats.
Cardiovasc Res. 80:123–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takeda Y, Ward SM, Sanders KM and Koh SD:
Effects of the gap junction blocker glycyrrhetinic acid on
gastrointestinal smooth muscle cells. Am J Physiol Gastrointest
Liver Physiol. 288:G832–G841. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tare M, Coleman HA and Parkington HC:
Glycyrrhetinic derivatives inhibit hyperpolarization in endothelial
cells of guinea pig and rat arteries. Am J Physiol Heart Circ
Physiol. 282:H335–H341. 2002.PubMed/NCBI
|
